Skip to main navigation Skip to search Skip to main content

Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer

  • Pietro Scilipoti
  • , Marco Moschini*
  • , Mario de Angelis
  • , Mattia Longoni
  • , Luca Afferi
  • , Chiara Lonati
  • , Paolo Zaurito
  • , Renate Pichler
  • , Andrea Necchi
  • , Francesco Montorsi
  • , Alberto Briganti
  • , Andrea Mari
  • , Wojciech Krajewski
  • , Ekaterina Laukthina
  • , Benjamin Pradere
  • , Francesco Del Giudice
  • , Laura Mertens
  • , Andrea Gallioli
  • , Francesco Soria
  • , Paolo Gontero
  • Simone Albisinni, Shahrokh F. Shariat, European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group
*Corresponding author for this work
  • IRCCS Ospedale San Raffaele
  • Kantonsspital Luzern
  • University of Brescia
  • Innsbruck Medical University
  • University of Florence
  • Wrocław Medical University
  • Medical University of Vienna
  • La Croix du Sud Hospital
  • University of Rome La Sapienza
  • Netherlands Cancer Institute
  • Autonomous University of Barcelona
  • Torino School of Medicine
  • University of Rome Tor Vergata
  • University of Texas Southwestern Medical Center
  • Karl Landsteiner Institute of Urology and Andrology
  • Cornell University
  • Charles University
  • Clinica Luganese Moncucco
  • Swiss Medical Group

Research output: Contribution to journalArticleAcademicpeer-review

63 Downloads (Pure)

Abstract

Objective: Sparse data exist on the impact of upper urinary tract (UUT) decompression on the risk of UUT recurrence in patients with bladder cancer (BCa). This study aims to evaluate whether Double J stenting (DJS) can increase the risk of UUT recurrence compared to percutaneous nephrostomy (PCN) placement. Materials and methods: We retrospectively analyzed data from 1550 patients with cTa-T3NanyM0 BCa who underwent radical cystectomy (RC) between at 12 tertiary care centers (1990-2020). Patients with complete follow-up, no prior history of UUT cancer, and who required UUT decompression for preoperative hydronephrosis were selected. Hydronephrosis grade was defined according to established scoring systems. UUT recurrence was diagnosed through imaging, urinary cytology, and confirmed by selective cytology and ureteroscopy when possible. Propensity scores were computed to determine overlap weights and balance groups. Kaplan–Meier analyses estimated UUT recurrence-free survival (RFS), cancer-specific (CSS), and overall survival (OS) before and after weighting. Cox regression analyses before and after weighting were fitted to predict UUT recurrence. Results: Of 524 included patients, 132 (25%) and 392 (75%) patients were managed with DJS and PCN placement, respectively. Patients who received PCN had higher grade (≥ 3) of obstruction (34% vs. 14%) and pT3-4 tumors (70% vs. 36%) than patients with DJS. During a median follow-up of 19 months, 2-years UUT-RFS did not differ between groups (95% for PCN vs 92% for DJS, weighted HR 1.41, 95% CI, 0.55-3.59). There was no difference in 2-years weighted CSS (74% vs. 74%) and OS (67% vs 69%). Main limitations were the short follow-up and inclusion of patients uniquely undergoing RC. Conclusions: These results suggest that ureteral DJS does not increase the risk of developing UUT recurrence in BCa patients with hydronephrosis requiring UUT decompression. However, UUT recurrence was rare, and associations were weak, with findings susceptible to bias. Randomized trials are needed to validate these results.
Original languageEnglish
Article number102241
JournalClinical genitourinary cancer
Volume22
Issue number6
DOIs
Publication statusPublished - 1 Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Double J
  • Hydronephrosis
  • Radical cystectomy
  • UUT recurrence
  • percutaneous nephrostomy

Fingerprint

Dive into the research topics of 'Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder Cancer'. Together they form a unique fingerprint.

Cite this